Label: DRUGGIST BRIGHTENING CREAM cream

  • NDC Code(s): 83872-193-01
  • Packager: Shenzhen Xiaomai Manufacturing Co Ltd
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated June 24, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENT

    Arbutin

  • PURPOSE

    whiten skin

  • INDICATIONS

    whiten skin

  • Warnings

    For external use only.

  • Do not use

    Do not use on damaged or brokenskin.

  • When using this product

    Wnen using tnis product keep out of eyes. Rinse with water to remove.

  • Stop use and ask a doctor

    Stop use and ask a doctor if rash occurs

  • Keep out of reach of children.

    Keep out of reach of children.

  • Directions for use

    Use twice daily, in the morning and evening.
    Apply an appropriate amount of cream evenly tothe cleansed face and neck.
    Gently massage until fully absorbed.
    Increase frequency of use as needed based onskin condition.

  • INACTIVE INGREDIENT

    Arbutin
    Aqua
    Glycerin
    Sodium Hyaluronate
    Stearyl Alcohol
    Propanediol
    Hydrogenated Lecithin
    Squalane
    Retinol

  • Other Information

    Store in a cool, dry place. "Avoid direct sunlight.
    Consult a dermatologist if you have any questions.

  • PRINCIPAL DISPLAY PANEL

    label

  • INGREDIENTS AND APPEARANCE
    DRUGGIST BRIGHTENING CREAM 
    druggist brightening cream cream
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:83872-193
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ARBUTIN (UNII: C5INA23HXF) (ARBUTIN - UNII:C5INA23HXF) ARBUTIN50 g  in 1 mg
    Inactive Ingredients
    Ingredient NameStrength
    SQUALANE (UNII: GW89575KF9) 50 g  in 1 mg
    GLYCERIN (UNII: PDC6A3C0OX) 600 g  in 1 mg
    AQUA REGIA (UNII: X3TT5X989E) 100 g  in 1 mg
    PEG-9 DIGLYCIDYL ETHER/SODIUM HYALURONATE CROSSPOLYMER (UNII: 788QAG3W8A) 50 g  in 1 mg
    CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S) 50 g  in 1 mg
    1,3-PROPANEDIOL BIS(4-AMINOBENZOATE) (UNII: 8860R9ORQR) 30 g  in 1 mg
    22-HYDROGENATED RACEMIC CALCIPOTRIOL (UNII: 96516X6183) 10 g  in 1 mg
    3,5-DIBROMOSALICYLIC ACID (UNII: T5JO5UA21H) 60 g  in 1 mg
    Product Characteristics
    ColorwhiteScore    
    ShapeSize
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:83872-193-0150 mg in 1 BOTTLE; Type 0: Not a Combination Product06/24/2024
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph Drug505G(a)(3)06/24/2024
    Labeler - Shenzhen Xiaomai Manufacturing Co Ltd (712999147)
    Establishment
    NameAddressID/FEIBusiness Operations
    Shenzhen Xiaomai Manufacturing Co Ltd712999147manufacture(83872-193)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!